World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
72100
World Ranking
241
National Ranking
158

Medicine

D-Index
131
Citations
72906
World Ranking
2374
National Ranking
1338

Francesco M. Marincola publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Francesco M. Marincola sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 746 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Francesco M. Marincola D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco M. Marincola sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 129 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Francesco M. Marincola is affiliated with the National Institutes of Health in the United States. The primary focus of their research lies at the intersection of medicine, biochemistry, genetics, and molecular biology, with a notable emphasis on oncology, molecular biology, immunology, genetics, and cancer research.

The scientist's work encompasses a range of topics that include:

  • CAR-T cell therapy research
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • Virus-based gene therapy research
  • CRISPR and genetic engineering
  • Immune cell function and interaction
  • Colorectal cancer treatments and studies

Francesco M. Marincola has contributed to numerous publications, with frequently appearing venues such as:

  • Journal of Translational Medicine
  • Regular and Young Investigator Award Abstracts
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology

Their recent academic papers reflect ongoing contributions to cancer research and immunotherapy. Notable publications include:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020), Journal for ImmunoTherapy of Cancer
  • CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances (2023), Molecular Cancer
  • Targeting immunogenic cell stress and death for cancer therapy (2024), Nature Reviews Drug Discovery
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020), Journal of Clinical Oncology
  • Germline genetic contribution to the immune landscape of cancer (2021), Immunity

Collaboration is a key component of Marincola's research environment, reflected by frequent co-authors such as:

  • Davide Bedognetti
  • Alessandra Cesano
  • Jérôme Galon
  • Zhifen Yang
  • Paolo A. Ascierto

Best Publications

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

    Noriho Iida;Amiran Dzutsev;C. Andrew Stewart;Loretta Smith

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • A human memory T cell subset with stem cell-like properties

    Luca Gattinoni;Enrico Lugli;Yun Ji;Zoltan Pos

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

    Francesco M. Marincola;Elizabeth M. Jaffee;Daniel J. Hicklin;Soldano Ferrone

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

    Stephen A. Migueles;M. Shirin Sabbaghian;W. Lesley Shupert;Maria P. Bettinotti

  • gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

    Douglas J. Schwartzentruber;David H. Lawson;Jon M. Richards;Robert M. Conry

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

    Jérôme Galon;Helen K. Angell;Helen K. Angell;Helen K. Angell;Davide Bedognetti;Francesco M. Marincola;Francesco M. Marincola

  • The role of BRAF V600 mutation in melanoma

    Paolo A. Ascierto;John M. Kirkwood;Jean Jacques Grob;Ester Simeone

  • High-fidelity mRNA amplification for gene profiling.

    Ena Wang;Lance D. Miller;Galen A. Ohnmacht;Edison T. Liu

  • Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma

    John F. Toso;Vee J. Gill;Patrick Hwu;Francesco M. Marincola

  • Tumour immunity: effector response to tumour and role of the microenvironment.

    Alberto Mantovani;Pedro Romero;A Karolina Palucka;Francesco M Marincola

  • Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

    Soldano Ferrone;Francesco M. Marincola

  • Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

    Nicholas P. Restifo;Francesco M. Marincola;Yutaka Kawakami;Jeff Taubenberger

  • The dual role of IL-10

    Simone Mocellin;Monica C Panelli;Ena Wang;Dirk Nagorsen

  • The immune score as a new possible approach for the classification of cancer

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Magdalena Thurin

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

Frequent Co-Authors

Ena Wang
Ena Wang Toro bio
David F. Stroncek
David F. Stroncek National Institutes of Health
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Soldano Ferrone
Soldano Ferrone Harvard University
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing, for example, offers a pathway to work closely with immunology patients and research. Prospective students might consider online BSN programs for non nurses, which provide an accessible option for individuals without a prior nursing background.

Accelerated paths into nursing are also popular for those seeking faster transitions. The easiest ABSN programs to get into offer streamlined curricula designed to help students quickly gain nursing qualifications and enter clinical settings where immunology expertise is valuable.

Additionally, Licensed Practical Nurse (LPN) programs serve as an entry point into healthcare roles. Identifying which LPN programs are easiest to get into can aid applicants in selecting schools that match their academic and scheduling needs without compromising quality education.

For those aiming to advance further, nurse practitioner degrees offer advanced clinical roles. Many consider the easiest online nurse practitioner programs to balance career progression with flexibility, often focusing on specialties connected to immunological health conditions.

Best Scientists Citing Francesco M. Marincola

Trending Scientists

Recently Published Articles